HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Sisomicin

HCID 36119
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
32385-11-8
Standard SMILES
CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O
InChIKey
URWAJWIAIPFPJE-YFMIWBNJSA-N
Molecular formula
C19H37N5O7
Average molar mass
447.5 g/mol

Overview

Sisomycin is an amino cyclitol glycoside, an aminoglycoside antibiotic, a beta-L-arabinoside and a monosaccharide derivative.

Names & identifiers

Preferred name
Sisomicin
IUPAC
(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
English name
Sisomicin
Molecular formula
C19H37N5O7
Molecular weight
447.53

Names & synonyms

sisomicinRickamicin32385-11-8SisomycinSissomicinAntibiotic 66-40SisomicinaSisomicineAntibiotic 6640SisomicinumSch 13475Dehydrogentamicin Cla
Show more names
SiseptinSisomicin baseSisomicin (8CI)Sisomicin USP/EP/BPSisomicin impurity 1
X55XSL74YQ4,5 DehydrogentamicinSch13475CHEBI:9169(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diolD-Streptamine, O-3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1-4))-2-deoxy-Sizomycin(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yloxy]-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranoside

Database identifiers

CAS
32385-11-8
PubChem CID
36119
ChEMBL
CHEMBL221886
ChEBI
CHEBI:9169

Properties

Computed structural properties

XLogP
-5.1
Topological polar surface area
214 Ų
Hydrogen bond donors
8
Hydrogen bond acceptors
12
Rotatable bonds
6
Heavy atoms
31
Formal charge
0
Complexity
643

Experimental & physicochemical properties

Drugs · 2 items

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Listed in ZINC15

Physicochemical properties

Melting point
80 · 80-93°C
Boiling point
556.56 °C · 556.56°C (rough estimate)
Density
1.2777 · 1.2777 (rough estimate)
refractive index
1.76 · 1.7600 (estimate)
storage temp.
-20 °C · Hygroscopic, -20°C Freezer, Under Inert Atmosphere
solubility
Aqueous Acid (Slightly), DMSO (Slightly), Methanol (Slightly), Water (Slightly,
form
Solid
pka
13.29 · 13.29±0.70(Predicted)
color
Pale Yellow to Yellow
FDA UNII
55 XSL74YQ · X55XSL74YQ
ATC code
1 GB08 · J01GB08

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H312 (100%): Harmful in contact with skin [Warning Acute toxicity, dermal]

P203, P261, P271, P280, P302+P352, P304+P340, P317, P318, P321, P362+P364, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory InformationREACH registered substance: Sisomicin (EC: 251-018-2)
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Safety data

Signal word
Danger
Symbol(GHS)
GHS07,GHS08
Hazard statements
H332-H360-H312
REACH Registrations
Inactive
Precautionary statements
P261-P271-P304+P340-P312-P280-P302+P352-P312-P322-P363-P501

Chemistry & industry

Pharmacology

ATC Code · 2 items

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

MeSH Pharmacological Classification · 2 items

Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins.

Substances that inhibit the growth or reproduction of BACTERIA.

Applications · 4 items

DescriptionSisomicin was found in the culture broth of Micromonospora inyoensis by Schering-Plough Co. in 1970, following the discovery of gentamicin by the same research group. The structure and activity of sisomicin are very similar to those of gentamicin C1a, the major component of the gentamicin complex. Sisomicin shows stronger bacterial activity and lower renal and ototoxicity than gentamicin C1a .

UsesSisomicin is an Antibacterial. Gentamicin-like aminoglycoside antibiotic; has broad spectrum antibiotic activity.

Usesantibacterial, binds to ribosomes

General DescriptionThis aminoglycoside antibiotic is produced by Micromonospora inyoensis. Sisomicin is very similar to gentamicin in its antimicrobial spectrum and all other properties. It is as active as gentamicin against all Enterobacteriaceae . Against Pseudomonas aeruginosa, sisomicin is more active than gentamicin, but not as active as tobramycin. There is almost complete cross-resistance between gentamicin and sisomicin with most Gram-negative bacilli. The reason for this is that sisomicin, like gentamicin, is affected by at least eight of the plasmid-coded modifying enzymes, which can be produced by Gram-negative bacilli). On the other hand, sisomicin is active against some organisms which resist gentamicin by nonenzymatic mechanisms. Sisomicin does not offer significant advantages over gentamicin. It has had limited clinical trials, and has been available commercially in Europe as a sulfate, but not in the USA, UK, and Australia. The drug dosage of sisomicin (3–6 mg/kg/day), its methods of administration, and pharmacokinetics, are similar to those of gentamicin. The toxicity of these two drugs is also probably about the same. Results of treatment of conditions, such as urinary tract infections or Gramnegative bacillary septicemias, have, in general, been similar to what would be expected from an identical gentamicin regimen.

Related reactions

2 records
New reaction record
HRID 1415073 reaction equation
HRID 1415073As reactant
HRID 1758030 reaction equation
HRID 1758030As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
UNII
X55XSL74YQ
EC Number
251-018-2
Nikkaji
J342.544D
Symbol(GHS)
7 · GHS07,GHS08
Signal word
Danger
Hazard statements
332 · H332-H360-H312
Precautionary statements
261 · P261-P271-P304+P340-P312-P280-P302+P352-P312-P322-P363-P501
REACH Registrations
Inactive

Upstream & downstream products

Upstream raw materials

DextrinSOYBEAN MEALD-Streptamine, O-2,6-bis(acetylamino)-2,3,4,6-tetradeoxy-α-D-glycero-hex-4-enopyranosyl-(1→4)-O-[3-deoxy-4-C-methyl-3-(methylamino)-β-L-arabinopyranosyl-(1→6)]-N3-acetyl-2-deoxy-N1-ethyl- (9CI)

Downstream products

NETILMICIN

Additional notes

DefinitionChEBI: Sisomycin is an amino cyclitol glycoside, an aminoglycoside antibiotic, a beta-L-arabinoside and a monosaccharide derivative.